Drug Abuse Control Amendments of 1965: Hearings ... Eighty-ninth Congress, First Session, on H.R. 2, a Bill to Protect the Public Health and Safety by Amending the Federal Food, Drug, and Cosmetic Act to Establish Special Controls for Depressant and Stimulant Drugs, and for Other Purposes, January 27, 28; February 2, 9, and 10, 1965U.S. Government Printing Office, 1965 - 384 sider |
Andre utgaver - Vis alle
Vanlige uttrykk og setninger
abstinence adults alcohol amended amphetamines amphetamines and barbiturates authority barbiturates and amphetamines barbituric acid bill biturates BRILL butabarbital central nervous system CHAIRMAN chemical chlordiazepoxide clinical Commissioner LARRICK Congress convulsions Cosmetic Act counterfeit drugs dangerous drugs depressant and stimulant depressant drugs depressant or stimulant dispensing distribution doctor dosage dose drug abuse Drug Administration effect ethchlorvynol ethinamate exempt Federal Food Food and Drug GILLIGAN glutethimide grams hospital hypnotic illegal ingestion inspection inspectors intoxication JEHLE legislation MACDONALD manufacturers McMullen meprobamate methyprylon milligrams nonbarbiturate OREN HARRIS patients percent person PETERS pharmaceutical pharmacists pharmacy phenobarbital phenothiazine physical dependence physicians PICKLE pills potential for abuse prescribed prescription drugs problem provisions public health question Rauwolfia records regulation ROGERS of Florida ROOKE secobarbital Secretary sedative seizure SMOYER sodium SPRINGER stimulant drugs suicide symptoms tablets Thank tion tranquilizers truck violation wholesalers withdrawal
Populære avsnitt
Side 69 - Drug Addiction is a state of periodic or chronic intoxication produced by the repeated consumption of a drug (natural or synthetic) . Its characteristics include: 1. an overpowering desire or need (compulsion) to continue taking the drug and to obtain it by any means; 2. a tendency to increase the dose; 3. a psychic (psychological) and generally a physical dependence on the effects of the drug; 4.
Side 13 - ... (B) no conveyance shall be forfeited under the provisions of this section by reason of any act or omission established by the owner thereof to have been committed or omitted by any person other than such owner while such conveyance was unlawfully in the possession of a person other than the owner in violation of the criminal laws of the United States, or of any State.
Side 17 - counterfeit drug" means a drug which, or the container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, or device, or any likeness thereof, of a drug manufacturer, processor, packer, or distributor other than the person or persons who in fact manufactured, processed, packed, or distributed such drug and which thereby falsely purports or is represented to be the product of, or to have been packed or distributed by, such other drug manufacturer,...
Side 9 - Act shall take effect on the first day of the seventh calendar month following the month in which this Act is enacted; except that (1...
Side 7 - ... be subject to imprisonment for not more than two years, or a fine of not more than $5,000, or both such imprisonment and fine...
Side 117 - Exercise the usual precautions regarding size of the prescription for depressed or suicidal patients. In elderly and debilitated patients, use the lowest possible dosage (see Dosage and Administration).
Side 5 - ... such combinations, quantity, proportion, or concentration as to vitiate the potential for abuse of the substances which do have a depressant or stimulant effect on the central nervous system.
Side 142 - ... (3) any drug which contains any quantity of a substance which the Secretary, after investigation, has found to have, and by regulation designates as having, a potential for abuse because of its depressant or stimulant effect on the central nervous system or its hallucinogenic effect...
Side 116 - Drug addiction is a state of periodic or chronic intoxication detrimental to the individual and to society produced by the repeated consumption of a drug (natural or synthetic).
Side 186 - (3) The provisions of paragraphs (1) and (2) of this subsection shall not apply to a licensed practitioner described in subsection (a) (4) with respect to any depressant or stimulant drug received, prepared, processed, administered, or dispensed by him in the course of his professional practice, unless such practitioner regularly engages in dispensing any such drug or drugs to his patients for which they are charged, either separately or together with charges for other professional services.